Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

Acrochordon With Histological Features of Lichen Sclerosus.

Arnold KA, Sundharkrishnan L, Bolotin D, Shea CR.

Am J Dermatopathol. 2019 Jun;41(6):e64-e65. doi: 10.1097/DAD.0000000000001356.

PMID:
30946102
2.

Prognostic role of tumoral PDL1 expression and peritumoral FoxP3+ lymphocytes in vulvar melanomas.

Chłopik A, Selim MA, Peng Y, Wu CL, Tell-Marti G, Paral KM, Shalin SC, Kraft S, Hsu CK, Shea CR, Puig S, Fernandez-Figueras MT, Biernat W, Ryś J, Marszalek A, Hoang MP.

Hum Pathol. 2018 Mar;73:176-183. doi: 10.1016/j.humpath.2017.12.022. Epub 2018 Jan 4.

PMID:
29307625
3.

Autophagy gene ATG7 regulates ultraviolet radiation-induced inflammation and skin tumorigenesis.

Qiang L, Sample A, Shea CR, Soltani K, Macleod KF, He YY.

Autophagy. 2017;13(12):2086-2103. doi: 10.1080/15548627.2017.1380757.

4.

Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature.

Haugh AM, Njauw CN, Bubley JA, Verzì AE, Zhang B, Kudalkar E, VandenBoom T, Walton K, Swick BL, Kumar R, Rana HQ, Cochrane S, McCormick SR, Shea CR, Tsao H, Gerami P.

JAMA Dermatol. 2017 Oct 1;153(10):999-1006. doi: 10.1001/jamadermatol.2017.2330. Review.

5.

KIT mutations and CD117 overexpression are markers of better progression-free survival in vulvar melanomas.

Dias-Santagata D, Selim MA, Su Y, Peng Y, Vollmer R, Chłopik A, Tell-Marti G, Paral KM, Shalin SC, Shea CR, Puig S, Fernandez-Figueras MT, Biernat W, Ryś J, Marszalek A, Hoang MP.

Br J Dermatol. 2017 Nov;177(5):1376-1384. doi: 10.1111/bjd.15836. Epub 2017 Nov 5. Erratum in: Br J Dermatol. 2018 Mar;178(3):815.

PMID:
28734009
6.

Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group.

Lott JP, Elmore JG, Zhao GA, Knezevich SR, Frederick PD, Reisch LM, Chu EY, Cook MG, Duncan LM, Elenitsas R, Gerami P, Landman G, Lowe L, Messina JL, Mihm MC, van den Oord JJ, Rabkin MS, Schmidt B, Shea CR, Yun SJ, Xu GX, Piepkorn MW, Elder DE, Barnhill RL; International Melanoma Pathology Study Group.

J Am Acad Dermatol. 2016 Aug;75(2):356-63. doi: 10.1016/j.jaad.2016.04.052. Epub 2016 May 14.

7.

Eccrine squamous syringometaplasia in sites of radiation recall secondary to vemurafenib therapy for BRAF-mutated carcinoma.

Moioli EK, Ligtenberg KG, Kenkare S, Shea CR, Soltani K.

J Dermatol. 2016 Oct;43(10):1233-1234. doi: 10.1111/1346-8138.13369. No abstract available.

PMID:
27094584
8.

Cellular Blue Nevomelanocytic Lesions: Analysis of Clinical, Histological, and Outcome Data in 37 Cases.

Hung T, Argenyi Z, Erickson L, Guitart J, Horenstein MG, Lowe L, Messina J, Piepkorn MW, Prieto VG, Rabkin MS, Schmidt B, Selim MA, Shea CR, Trotter MJ, Barnhill RL.

Am J Dermatopathol. 2016 Jul;38(7):499-503. doi: 10.1097/DAD.0000000000000483.

PMID:
26909585
9.

Early morphea simulating patch-stage mycosis fungoides.

Fujimoto M, Basko-Plluska JL, Petronic-Rosic V, Shea CR.

Am J Dermatopathol. 2015 May;37(5):409-12. doi: 10.1097/DAD.0000000000000271.

PMID:
25768945
10.

Melanocytic tumors with intraepidermal melanophages: a report of five cases with review of 231 archived cutaneous melanocytic tumors.

Fujimoto M, Basko-Plluska JL, Krausz T, Selim MA, Shea CR.

J Cutan Pathol. 2015 Jun;42(6):394-9. doi: 10.1111/cup.12479. Epub 2015 Mar 27.

PMID:
25733008
11.

Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma.

Clarke LE, Warf MB, Flake DD 2nd, Hartman AR, Tahan S, Shea CR, Gerami P, Messina J, Florell SR, Wenstrup RJ, Rushton K, Roundy KM, Rock C, Roa B, Kolquist KA, Gutin A, Billings S, Leachman S.

J Cutan Pathol. 2015 Apr;42(4):244-52. doi: 10.1111/cup.12475. Epub 2015 Apr 13.

PMID:
25727210
12.

Epstein-Barr virus-encoded RNA in-situ hybridization on non-specific ulcerative skin lesions of immunosuppressed patients.

Fujimoto M, Basko-Plluska JL, Shea CR.

Histopathology. 2015 Sep;67(3):416-7. doi: 10.1111/his.12644. Epub 2015 Mar 5. No abstract available.

PMID:
25560062
13.

Diameter of dysplastic nevi is a more robust biomarker of increased melanoma risk than degree of histologic dysplasia: a case-control study.

Xiong MY, Rabkin MS, Piepkorn MW, Barnhill RL, Argenyi Z, Erickson L, Guitart J, Lowe L, Shea CR, Trotter MJ, Lew RA, Weinstock MA.

J Am Acad Dermatol. 2014 Dec;71(6):1257-1258.e4. doi: 10.1016/j.jaad.2014.07.030. Epub 2014 Nov 15. No abstract available.

PMID:
25454033
14.

Loss of sirtuin 1 (SIRT1) disrupts skin barrier integrity and sensitizes mice to epicutaneous allergen challenge.

Ming M, Zhao B, Shea CR, Shah P, Qiang L, White SR, Sims DM, He YY.

J Allergy Clin Immunol. 2015 Apr;135(4):936-45.e4. doi: 10.1016/j.jaci.2014.09.035. Epub 2014 Nov 7.

15.

Eruptive cutaneous squamous cell carcinoma and psoriasis: response to cetuximab.

Kamaria M, Shea CR, Chin RK, Cohen EE, Maggiore R, Bolotin D.

Clin Exp Dermatol. 2014 Jul;39(5):604-7. doi: 10.1111/ced.12341. Epub 2014 Apr 23.

PMID:
24758726
16.

Dual role of SIRT1 in UVB-induced skin tumorigenesis.

Ming M, Soltani K, Shea CR, Li X, He YY.

Oncogene. 2015 Jan 15;34(3):357-63. doi: 10.1038/onc.2013.583. Epub 2014 Jan 20.

17.

Baseline comorbidities in a skin cancer prevention trial in Bangladesh.

Argos M, Rahman M, Parvez F, Dignam J, Islam T, Quasem I, K Hore S, T Haider A, Hossain Z, I Patwary T, Rakibuz-Zaman M, Sarwar G, La Porte P, Harjes J, Anton K, Kibriya MG, Jasmine F, Khan R, Kamal M, Shea CR, Yunus M, Baron JA, Ahsan H.

Eur J Clin Invest. 2013 Jun;43(6):579-88. doi: 10.1111/eci.12085. Epub 2013 Apr 17.

18.

Melanocytes, melanocyte stem cells, and melanoma stem cells.

Lang D, Mascarenhas JB, Shea CR.

Clin Dermatol. 2013 Mar-Apr;31(2):166-78. doi: 10.1016/j.clindermatol.2012.08.014. Review.

19.

Borderline sebaceous neoplasm in a renal transplant patient without Muir-Torre syndrome.

Kaminska EC, Iyengar V, Tsoukas M, Shea CR.

J Cutan Pathol. 2013 Mar;40(3):336-40. doi: 10.1111/cup.12046. Epub 2012 Nov 23.

PMID:
23174034
20.

Blistering eruption on the chest of a 30-year-old pregnant woman.

Bangash HK, Patel S, Soltani K, Shea CR, Sethi A.

Int J Dermatol. 2012 Dec;51(12):1429-31. doi: 10.1111/j.1365-4632.2012.05636.x. No abstract available.

PMID:
23171009
21.

Immunohistochemistry for immunoglobulin G4 on paraffin sections for the diagnosis of pemphigus.

Zhang X, Hyjek E, Soltani K, Petronic-Rosic V, Shea CR.

Arch Pathol Lab Med. 2012 Nov;136(11):1402-7. doi: 10.5858/arpa.2011-0425-OA.

PMID:
23106586
22.

Expression of MiTF may be helpful in differentiating cellular neurothekeoma from plexiform fibrohistiocytic tumor (histiocytoid predominant) in a partial biopsy specimen.

Fox MD, Billings SD, Gleason BC, Moore J, Thomas AB, Shea CR, Victor TA, Cibull TL.

Am J Dermatopathol. 2012 Apr;34(2):157-60. doi: 10.1097/DAD.0b013e3182286a03.

PMID:
22441367
23.

Clinical decision making based on histopathologic grading and margin status of dysplastic nevi.

Duffy KL, Mann DJ, Petronic-Rosic V, Shea CR.

Arch Dermatol. 2012 Feb;148(2):259-60. doi: 10.1001/archdermatol.2011.2045. No abstract available.

PMID:
22351835
24.

PTEN positively regulates UVB-induced DNA damage repair.

Ming M, Feng L, Shea CR, Soltani K, Zhao B, Han W, Smart RC, Trempus CS, He YY.

Cancer Res. 2011 Aug 1;71(15):5287-95. doi: 10.1158/0008-5472.CAN-10-4614. Epub 2011 Jul 19.

25.

Sorafenib-induced eruption resembling pityriasis rubra pilaris.

Paz C, Querfeld C, Shea CR.

J Am Acad Dermatol. 2011 Aug;65(2):452-453. doi: 10.1016/j.jaad.2010.03.015. No abstract available.

PMID:
21763585
26.

Immunohistochemistry of melanocytic proliferations.

Prieto VG, Shea CR.

Arch Pathol Lab Med. 2011 Jul;135(7):853-9. doi: 10.1043/2009-0717-RAR.1. Review.

PMID:
21732774
27.

The recurrent nevus phenomenon: a history of challenge, controversy, and discovery.

Fox JC, Reed JA, Shea CR.

Arch Pathol Lab Med. 2011 Jul;135(7):842-6. doi: 10.1043/2010-0429-RAR.1. Review.

PMID:
21732772
28.

Lentigo maligna: melanoma in situ on chronically sun-damaged skin.

Reed JA, Shea CR.

Arch Pathol Lab Med. 2011 Jul;135(7):838-41. doi: 10.1043/2011-0051-RAIR.1. Review.

PMID:
21732771
29.

Cutaneous Churg-Strauss syndrome: response to dapsone therapy.

Bolotin D, Petronic-Rosic V, Shea CR.

J Am Acad Dermatol. 2011 Jul;65(1):244-6. doi: 10.1016/j.jaad.2009.12.057. No abstract available.

PMID:
21679841
30.

Dermatopathologic effects of taxane therapy.

Plummer RS, Shea CR.

J Am Acad Dermatol. 2011 Sep;65(3):592-596. doi: 10.1016/j.jaad.2010.07.033. Epub 2011 Apr 17.

PMID:
21501891
31.

Nevus versus melanoma: to FISH, or not to FISH.

Song J, Mooi WJ, Petronic-Rosic V, Shea CR, Stricker T, Krausz T.

Adv Anat Pathol. 2011 May;18(3):229-34. doi: 10.1097/PAP.0b013e3182169b69. Review.

PMID:
21490440
32.

UVA induces lesions resembling seborrheic keratoses in mice with keratinocyte-specific PTEN downregulation.

Ming M, Shea CR, Feng L, Soltani K, He YY.

J Invest Dermatol. 2011 Jul;131(7):1583-6. doi: 10.1038/jid.2011.33. Epub 2011 Mar 10. No abstract available.

33.

Tender papules and plaques adjacent to a scar--quiz case. Subcutaneous and cutaneous sarcoidosis.

Guerrero C, Paz C, Green E, Shea CR.

Arch Dermatol. 2011 Jan;147(1):109-14. doi: 10.1001/archdermatol.2010.402-a. No abstract available.

PMID:
21242404
34.

Disseminated follicular eruption during therapy with the MEK inhibitor AZD6244.

Querfeld C, Duffy K, Magel G, Oble D, Cohen EE, Shea CR.

J Am Acad Dermatol. 2011 Feb;64(2):e17-9. doi: 10.1016/j.jaad.2009.06.070. No abstract available.

PMID:
21238821
35.

Regulation of global genome nucleotide excision repair by SIRT1 through xeroderma pigmentosum C.

Ming M, Shea CR, Guo X, Li X, Soltani K, Han W, He YY.

Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22623-8. doi: 10.1073/pnas.1010377108. Epub 2010 Dec 13.

36.

Arsenical keratoses in Bangladesh--update and prevention strategies.

Ruiz de Luzuriaga AM, Ahsan H, Shea CR.

Dermatol Clin. 2011 Jan;29(1):45-51. doi: 10.1016/j.det.2010.09.003. Review.

PMID:
21095527
37.

"Pruritis" redux.

Shea CR.

Arch Dermatol. 2010 Aug;146(8):924. doi: 10.1001/archdermatol.2010.166. No abstract available.

PMID:
20713837
38.

Benign versus malignant parakeratosis: a nuclear morphometry study.

Song J, Shea CR.

Mod Pathol. 2010 Jun;23(6):799-803. doi: 10.1038/modpathol.2010.52. Epub 2010 Feb 26.

39.

UVB-induced ERK/AKT-dependent PTEN suppression promotes survival of epidermal keratinocytes.

Ming M, Han W, Maddox J, Soltani K, Shea CR, Freeman DM, He YY.

Oncogene. 2010 Jan 28;29(4):492-502. doi: 10.1038/onc.2009.357. Epub 2009 Nov 2.

40.

Molecular mechanisms of photodynamic therapy.

Ortel B, Shea CR, Calzavara-Pinton P.

Front Biosci (Landmark Ed). 2009 Jan 1;14:4157-72. Review.

PMID:
19273342
41.

Nephrogenic systemic fibrosis associated with stromal and vascular calcification, report of two cases.

Song J, Volkov S, Shea CR, Alegre ML, Salgia R, Gregg K, Curran JJ, Woodruff J, Krausz T, Levine JS, Sweiss NJ.

J Cutan Pathol. 2009 Oct;36 Suppl 1:31-4. doi: 10.1111/j.1600-0560.2008.01205.x. Epub 2008 Dec 4.

42.

Erythematous papules on the legs. IgM storage papules in association with WM.

Bernstein LE, Shea CR, Baron JM.

Arch Dermatol. 2009 Jan;145(1):77-82. doi: 10.1001/archdermatol.2008.556-a. No abstract available.

PMID:
19153352
43.

Use of immunohistochemistry in melanocytic lesions.

Prieto VG, Shea CR.

J Cutan Pathol. 2008 Nov;35 Suppl 2:1-10. doi: 10.1111/j.1600-0560.2008.01130.x. Review.

PMID:
18976412
44.

Memories of the McNutt fellowship.

Shea CR, Prieto VG.

J Cutan Pathol. 2008 Nov;35 Suppl 2:iv-vi. doi: 10.1111/j.1600-0560.2007.00876.x. No abstract available.

PMID:
18976411
45.

PAX3 expression in primary melanomas and nevi.

Plummer RS, Shea CR, Nelson M, Powell SK, Freeman DM, Dan CP, Lang D.

Mod Pathol. 2008 May;21(5):525-30. doi: 10.1038/modpathol.3801019. Epub 2008 Mar 7.

46.

Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus").

Barnhill RL, Argenyi Z, Berwick M, Duray PH, Erickson L, Guitart J, Horenstein MG, Lowe L, Messina J, Paine S, Piepkorn MW, Prieto V, Rabkin MS, Schmidt B, Selim A, Shea CR, Trotter MJ.

Am J Surg Pathol. 2008 Jan;32(1):36-44.

PMID:
18162768
47.

Cutaneous clear-cell granular cell tumors: the histologic description of an unusual variant.

Zedek DC, Murphy BA, Shea CR, Hitchcock MG, Reutter JC, White WL.

J Cutan Pathol. 2007 May;34(5):397-404.

PMID:
17448195
48.

Epidermolytic hyperkeratosis within infundibular cysts.

Steele CL, Shea CR, Petronic-Rosic V.

J Cutan Pathol. 2007 Apr;34(4):360-2.

PMID:
17381810
49.

Eosinophilic granuloma of the skin: response to intralesional corticosteroid injection.

Myers E, Shea CR, Krausz T, Petronic-Rosic V.

J Drugs Dermatol. 2007 Mar;6(3):329-32.

PMID:
17373196
50.

Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma.

Shors AR, Kim S, White E, Argenyi Z, Barnhill RL, Duray P, Erickson L, Guitart J, Horenstein MG, Lowe L, Messina J, Rabkin MS, Schmidt B, Shea CR, Trotter MJ, Piepkorn MW.

Br J Dermatol. 2006 Nov;155(5):988-93.

Supplemental Content

Support Center